Healthcare Sales & Marketing Network News: Pancreatic Cancer

Searching News Database: Pancreatic Cancer

HSMN NewsFeed - 10 Nov 2023
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 9 Jun 2023
Astellas Submits New Drug Application for Zolbetuximab in Japan
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 2 Mar 2023
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian(R) MRI-Guided Radiation Therapy
Devices Oncology

HSMN NewsFeed - 5 Dec 2022
Immunovia strengthens US organization to continue commercialization of its novel IMMray(TM) PanCan-d test
Diagnostics Oncology Personnel

HSMN NewsFeed - 24 Oct 2022
ViewRay Announces Primary Endpoint Outcome from First Prospective, Multi-Institutional Study to Deliver Ablative Doses of Radiation to Pancreatic Cancer Patients
Devices Oncology

HSMN NewsFeed - 19 Oct 2022
Immunovia Announces Executive Management Team Changes to Accelerate Execution of Strategic Priorities
Diagnostics Oncology Personnel

HSMN NewsFeed - 26 Apr 2022
Lantern Pharma's Board of Directors Names Maria Maccecchini, Ph.D. as a Director Nominee to Lantern's Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Mar 2022
University Hospital Agostino Gemelli Treats its 1,000th Patient Using MRIdian(R) MRI-Guided Radiation Therapy
Devices Oncology

HSMN NewsFeed - 24 Nov 2021
ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide
Devices Oncology

HSMN NewsFeed - 20 Oct 2021
vTv Therapeutics Announces Deepa Prasad as New President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Sep 2021
RenovoRx Receives New 510(k) Clearance for its RenovoCath(R) Delivery System Designed for Targeted Treatment of Solid Tumors
Devices Drug Delivery Oncology FDA

HSMN NewsFeed - 11 Aug 2021
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-184 in the Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 12 Jul 2021
Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 May 2021
FDA Grants Bold Therapeutics' BOLD-100 an Orphan Drug Designation (ODD) in the Treatment of Gastric Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 23 Feb 2021
Elicio Therapeutics Announces FDA Clearance of IND application for ELI-002-- A Therapeutic Vaccine Targeting mutated KRAS Cancers
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Jan 2021
The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian(R) Linac
Devices Oncology

HSMN NewsFeed - 23 Dec 2020
Rakuten Medical Enrolls First Patient in the U.S. Clinical Trial for its Lead Product, ASP-1929 in Combination with Anti-PD1 Therapy, for Head and Neck Cancer or Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Dec 2020
Servier to Acquire Agios Pharmaceuticals' Oncology Business
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 10 Nov 2020
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Oct 2020
CARsgen Therapeutics Granted Orphan Drug Designation by the US FDA for CT041 CLDN18.2 CAR-T Cells for the Treatment of Gastric and Gastroesophageal Junction Cancers
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 27 Jul 2020
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Jun 2020
Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round
Devices Oncology Venture Capital

HSMN NewsFeed - 3 Jun 2020
Norwegian EXACT Therapeutics Appoints Rafiq Hasan as CEO
Devices Drug Delivery Personnel

HSMN NewsFeed - 27 Apr 2020
CARsgen Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for Fully Human Anti-BCMA CAR-T Cells (CT053) for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 20 Apr 2020
Moleculin Announces Agreement with ImQuest Biosciences to Expand Coronavirus Testing
Biopharmaceuticals

HSMN NewsFeed - 24 Mar 2020
Apexigen Completes $123 Million Series C Financing To Advance Clinical Pipeline
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 6 Jan 2020
CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Dec 2019
OBI Pharma Granted FDA Orphan Drug Designation for the Treatment of Pancreatic Cancer for Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 19 Dec 2019
Michigan Community Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
Devices Oncology

HSMN NewsFeed - 31 Oct 2019
Cytotron(R) Granted 'Breakthrough Device Designation' by U.S. FDA for Treatment of Breast, Liver, and Pancreatic Cancers
Devices Oncology FDA

HSMN NewsFeed - 15 Oct 2019
Cyteir Therapeutics Secures Additional $40.2 Million in Its Series B Financing and Doses First Patient in Phase 1/2 Study of First-in-Class RAD51 Inhibitor
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 3 Sep 2019
Laboratory for Advanced Medicine Receives FDA Breakthrough Device Designation for Liquid Biopsy Liver Cancer Detection Test
Diagnostics Oncology FDA

HSMN NewsFeed - 19 Jun 2019
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the U.S. FDA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 5 Apr 2019
Hoag Radiation Oncology, USA, Selects RayStation as Their New Treatment Planning System
Devices Oncology

HSMN NewsFeed - 4 Feb 2019
BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Jan 2019
ViewRay Announces First Patient Enrolled in Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) Trial for Locally Advanced Pancreatic Cancer
Devices Oncology

HSMN NewsFeed - 28 Nov 2018
MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 21 Nov 2018
OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 10 Oct 2018
OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Submission of Investigational New Drug Application to Evaluate Tedopi(R) in Combination with Nivolumab in Pancreatic Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 5 Sep 2018
Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
Devices Radiology Oncology Venture Capital

HSMN NewsFeed - 21 Aug 2018
Alpha Tau's High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United States
Devices Oncology Regulatory

HSMN NewsFeed - 16 Aug 2018
Rafael Pharmaceuticals Receives FDA Orphan Drug Designation of CPI-613 for the Treatment of Peripheral T-Cell Lymphoma (PTCL)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Aug 2018
Apexigen Raises $73 Million In Series B And Series C Financings
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 26 Jul 2018
Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE(R) Technology
Biopharmaceuticals Oncology Drug Delivery

HSMN NewsFeed - 11 Jul 2018
FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
Biopharmaceuticals Drug Delivery Oncology FDA

HSMN NewsFeed - 3 Jul 2018
MabVax Therapeutics Grants Exclusive Sublicense to Y-mAbs Therapeutics for Patented Neuroblastoma Vaccine
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 22 Jun 2018
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Jun 2018
Caris Life Sciences Presents Data Demonstrating the Ability of ADAPT Biotargeting System to Identify Responders and Non-Responders in a Phase III Pancreatic Cancer Study
Diagnostics Oncology

HSMN NewsFeed - 10 May 2018
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 10 May 2018
Lilly Announces Agreement To Acquire ARMO BioSciences
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 9 Apr 2018
Intezyne Promotes Adam Carie, PhD to Director, Product Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 20 Mar 2018
Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin(R) Injection
Biopharmaceuticals Generics Oncology Product Launch

HSMN NewsFeed - 15 Mar 2018
Intezyne Taps Veteran Banker E. Russell McAllister as President and CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Mar 2018
Cyteir Therapeutics Secures $29 Million Series B to Advance Novel, Molecularly Targeted Therapies for Cancer and Autoimmune Diseases
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 2 Mar 2018
CARsgen Completed $60 Million Pre-C Financing Framework Agreements
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 16 Jan 2018
MabVax Therapeutics Holdings, Inc. Provides Business Strategy Update
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Nov 2017
NewLink Genetics Appoints Eugene Kennedy, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Nov 2017
Genisphere Raises $7 Million to Advance 3DNA(R) Drug Delivery System
Biopharmaceuticals Oncology Drug Delivery Venture Capital

HSMN NewsFeed - 6 Oct 2017
Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 14 Sep 2017
Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 29 Aug 2017
ARMO BioSciences Raises $67 Million in a Series C-1 Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 26 Jul 2017
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
Diagnostics Product Launch

HSMN NewsFeed - 5 Jun 2017
Bayer Expands Oncology Organization with Two New Leadership Team Appointments
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Apr 2017
Lilly Announces Phase 3 MONARCH 3 Breast Cancer Study of Abemaciclib Demonstrated Superior Progression-Free Survival at Interim Analysis
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Apr 2017
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 9 Mar 2017
OncoResponse Announces Final Closing of $22.5M Series A Financing Round
Biopharmaceuticals Oncology Personnel Venture Capital

HSMN NewsFeed - 8 Mar 2017
Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 17 Feb 2017
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Feb 2017
Daxor Corporation Announces Death of Founder, Chief Medical Officer, and Developer of Blood Volume Analysis and Inventor of the Daxor BVA-100 Device, Dr. Joseph Feldschuh
Diagnostics Personnel

HSMN NewsFeed - 20 Jan 2017
Verastem Announces Executive Leadership Appointments and Changes
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Jan 2017
Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 Jan 2017
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 14 Nov 2016
Boston Biomedical Announces Orphan Drug Designation for Napabucasin in Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Nov 2016
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 28 Oct 2016
Astellas to Acquire Ganymed Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Oct 2016
Shire Granted EU Marketing Authorization of Onivyde(R), in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV),for the Treatment of Metastatic Adenocarcinoma of the Pancreas in Adult Patients Who Have Progressed Following Gemcitabine-Based Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 6 Oct 2016
Interpace Diagnostics Launches New Streamlined Molecular Product for Pancreatic Cysts
Diagnostics Oncology Product Launch

HSMN NewsFeed - 30 Sep 2016
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus on Evofosfamide and Earlier-Stage Opportunities
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Sep 2016
BioLineRx Announces In-licensing of Novel Treatment for Liver Failure Conditions Under Strategic Collaboration
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Sep 2016
Installation Initiated for Elekta’s High-Field MR-Adaptive Linear Accelerator at Froedtert & the Medical College of Wisconsin Clinical Cancer Center
Devices Oncology

HSMN NewsFeed - 6 Sep 2016
OncoSec Appoints Sharron Gargosky, PhD, to Chief Clinical and Regulatory Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Aug 2016
BioLineRx Names Philip A. Serlin as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2016
ONIVYDE(R) Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Following Gemcitabine Based Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 May 2016
Interpace Diagnostics Presents New Clinical Utility Data at Digestive Disease Week
Diagnostic Gastroenterology Oncology

HSMN NewsFeed - 29 Apr 2016
Allergan Receives CHMP Positive Opinion For ENZEPI(R) (Pancrelipase) For Patients With Exocrine Pancreatic Insufficiency (EPI)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Apr 2016
Interpace Diagnostics Announces New Coding by Novitas Solutions for PancraGen(TM)
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 7 Apr 2016
VolitionRx Announces CE Marks for Two NuQ(R) Blood Assays for Detection of Colorectal Cancer
Diagnostics Oncology Regulatory

HSMN NewsFeed - 4 Apr 2016
BioLineRx's Novel Treatment for Non-Surgical Removal of Skin Lesions Receives CE Mark Approval
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 24 Mar 2016
Merrimack Announces Inclusion of ONIVYDE(R) (irinotecan liposome injection) as a Category 1 Treatment Option in the 2016 NCCN Guidelines for Pancreatic Adenocarcinoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Feb 2016
Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR(TM) Micro RNA Gene Expression Classifer
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 11 Feb 2016
Incyte Announces Decision to Discontinue JANUS Studies of Ruxolitinib plus Capecitabine in Patients with Advanced or Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Jan 2016
Abcodia Announces Expanded U.S. Availability of the ROCA(R) Test for Early Ovarian Cancer Detection
Diagnostics Oncology Product Launch

HSMN NewsFeed - 25 Jan 2016
Boston Biomedical's Investigational Cancer Stem Cell Pathway Inhibitor, Napabucasin (BBI608), Featured at the ASCO 2016 Gastrointestinal Cancers Symposium
Biopharmaceuticals Oncology Gastroenterology

HSMN NewsFeed - 23 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 21 Jan 2016
Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE(TM) Technology
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 20 Jan 2016
Interpace Diagnostics Announces New Medicare Local Coverage Determination for Molecular Testing of Pancreatic Cysts
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 12 Jan 2016
Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp
Diagnostics Oncology

HSMN NewsFeed - 8 Jan 2016
NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Dec 2015
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Dec 2015
Merck KGaA, Darmstadt, Germany, Decides Not to Pursue Evofosfamide Further in Soft Tissue Sarcoma and Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Oct 2015
Merrimack Announces U.S. FDA Approval of ONIVYDE(TM) (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 15 Oct 2015
Biothera Appoints Dr. Jose Iglesias as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Sep 2015
J. Robert Paulson and Jeffrey Mathiesen Appointed to Sun BioPharma Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 16 Sep 2015
David Kaysen Named President & CEO of Sun BioPharma
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Aug 2015
Immunomedics Appoints Arthur S. Kirsch as Director
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Aug 2015
Merrimack Pharmaceuticals Names Dr. Yasir Al-Wakeel as Chief Financial Officer and Head of Corporate Development
Biopharmaceuticals Drug Delivery Oncology Personnel

HSMN NewsFeed - 12 May 2015
Merck KGaA, Darmstadt, Germany, Receives FDA Fast Track Designation for Evofosfamide for the Treatment of Patients Living With Advanced Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 20 Apr 2015
Oasmia's Lead Cancer Product Paclical(R) Receives Market Approval in the Russian Federation
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Mar 2015
Hong Kong Authority Approves Abraxane(R) as First-Line Treatment For Late-Stage Pancreatic Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 26 Feb 2015
Boston Scientific Launches Next Generation SpyGlass(TM) DS Direct Visualization System For Advanced Diagnosis And Treatment Of Pancreatico-biliary Diseases
Devices Interventional Product Launch

HSMN NewsFeed - 5 Jan 2015
Aduro Biotech Closes $51.4 Million Series D Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 17 Dec 2014
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Biopharmaceuticlas Oncology Personnel

HSMN NewsFeed - 2 Dec 2014
Oncolytics Biotech(R) Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Pancreatic and Ovarian Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Nov 2014
FDA Grants Orphan Drug Designation to Merrimack Pharmaceuticals' MM-141 for the Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Sep 2014
Cyclacel Pharmaceuticals Appoints Samuel L. Barker, Ph.D., to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 29 May 2014
Aduro Announces License Agreement with Johnson & Johnson Innovation for Novel Immunotherapies for Prostate Cancer
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 1 May 2014
Merrimack Pharmaceuticals Announces MM-398 Achieves Primary Endpoint of Overall Survival in Phase 3 Trial in Post-Gemcitabine Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Feb 2014
Tiltan Pharma Raises $1.5 Million
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 24 Jan 2014
Novocure Enrolls First Patient in Pilot Clinical Trial of NovoTTF(TM) Therapy Plus Gemcitabine for First-line Treatment of Advanced Pancreatic Adenocarcinoma
Devices Oncology

HSMN NewsFeed - 24 Jan 2014
Margaret A. Tempero, MD, Named Editor-in-Chief of JNCCN
Oncology Personnel

HSMN NewsFeed - 25 Nov 2013
Cyclacel Announces Data Safety Monitoring Board Recommendation to Continue the SEAMLESS Phase 3 Trial of Sapacitabine in AML
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Nov 2013
Threshold Pharmaceuticals Announces New Clinical Data on TH-302 and Avastin(R) (Bevacizumab) in Recurrent Glioblastoma Following Bevacizumab Failure
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Oct 2013
Myriad myRisk(TM) Hereditary Cancer Test Is Highly Accurate in Key Validation Study
Diagnostics Oncology

HSMN NewsFeed - 6 Sep 2013
U.S. Food and Drug Administration Approves ABRAXANE(R) in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Aug 2013
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
Diagnostics Oncology Product Launch

HSMN NewsFeed - 14 Aug 2013
Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free Survival in Previously Untreated Follicular Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Jun 2013
GeneDx to Launch Comprehensive Breast Cancer Genetic Test
Diagnostics Oncology Product Launch

HSMN NewsFeed - 31 May 2013
Plexxikon Announces Program Update and Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Feb 2013
Onyx Pharmaceuticals Appoints Dr. Pablo Cagnoni as Executive Vice President, Global Research & Development and Technical Operations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 31 Jan 2013
Aduro Announces $6.5 Million Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 28 Jan 2013
Results from Active Biotech's Phase II/III ANYARA trial for the treatment of renal cell cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jan 2013
NewLink Genetics Appoints Mr. Brian Wiley as Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Nov 2012
Northern Centre for Cancer Care Acquires Two TrueBeam(TM) Devices from Varian Medical Systems to Deliver Advanced Radiosurgery Treatments
Devices Oncology

HSMN NewsFeed - 12 Nov 2012
Clovis Oncology Announces Negative Outcome of CO-101 in Pivotal LEAP Pancreatic Cancer Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Jul 2012
Addition of Tarceva(R) (erlotinib) to Nexavar(R) (sorafenib) did not Provide Additional Benefit to Patients with Unresectable Liver Cancer Versus Nexavar alone in Phase 3 Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 May 2012
Cook Expands Line of Endoscopic Ultrasound Needles with Addition of Smallest Gage on the Market Designed for Histological and Cytological Samples
Devices Oncology

HSMN NewsFeed - 25 Apr 2012
Threshold Pharmaceuticals Appoints Robert Simon as Senior Vice President of Regulatory Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Apr 2012
Thought Leaders in Radiation Medicine Convene to Discuss Safety and Advancements in Cancer Treatment
Devices Oncology

HSMN NewsFeed - 15 Mar 2012
Completed Clinical Trial Further Indicates Cell-in-a-Box(R) Encapsulation Technology Has the Potential to Treat a Wide Array of Solid Tumors
Biopharmaceuticals Drug Delivery Oncology

HSMN NewsFeed - 17 Feb 2012
Threshold Pharmaceuticals Appoints Dr. Tillman Pearce as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Feb 2012
Boston Scientific Announces Global Launch of Expect(TM) 19 Flex Endoscopic Ultrasound Aspiration Needle
Devices

HSMN NewsFeed - 3 Feb 2012
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Oct 2011
New Stent Provides Relief to Patients with Advanced Small Intestine Cancer
Devices Gastroenterology FDA

HSMN NewsFeed - 11 Oct 2011
Aduro BioTech Announces First Patient Treated in Phase 2 Pancreatic Cancer Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Sep 2011
FibroGen Appoints Michael Martinelli, Ph.D., Vice President of Technical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jul 2011
Polaris Group Doses First Patient in Pivotal Phase 3 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 for the Treatment of Hepatocellular Carcinoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Jul 2011
Agennix Hires Christine Boisclair as Senior Vice President of Global Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jun 2011
BSD Medical Announces Clinical Role of Hyperthermia Was the Focus at European Society for Hyperthermic Oncology Meeting
Devices Oncology

HSMN NewsFeed - 31 May 2011
Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 20 May 2011
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 9 May 2011
Boston Scientific Begins U.S. and International Launch of Expect Endoscopic Ultrasound Aspiration Needle
Devices Gastroenterology

HSMN NewsFeed - 20 Apr 2011
Aduro BioTech Completes $19.25 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Mar 2011
Asuragen Launches CE Marked IVD AmplideX(TM) Fragile X Test in Europe
Diagnostics Regulatory

HSMN NewsFeed - 15 Mar 2011
Incyte’s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Jan 2011
Precision Therapeutics Announces Two Pancreatic Cancer Studies Emphasizing the Utility of ChemoFx(R) in Cancer Treatment Options
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 12 Jan 2011
Eurand Announces Agreement With Nycomed for ZENPEP(R) in Russia-CIS
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 20 Dec 2010
Myriad Genetics Launches PANEXIA, New Predictive Test for Hereditary Pancreatic and Related Cancers
Diagnostics Oncology

HSMN NewsFeed - 10 Dec 2010
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Dec 2010
SUTENT(R) Receives European Approval for a New Indication in Progressive Pancreatic Neuroendocrine Tumors (NET)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 1 Nov 2010
Neogenix Oncology(R) Receives FDA Orphan Drug Status for Ensituximab (NPC-1C) for Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 1 Nov 2010
Calypso Medical Introduces Dynamic Edge(TM) Gating Technology at ASTRO
Devices Oncology

HSMN NewsFeed - 1 Nov 2010
Doctors in the US and Europe Using TrueBeam System from Varian Medical Systems to Treat Cancers of the Lung, Liver, Pancreas, Head and Neck, Brain, and Spine
Devices Oncology

HSMN NewsFeed - 29 Oct 2010
Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting
Devices Oncology

HSMN NewsFeed - 21 Oct 2010
Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix Biliary Stents
Devices Interventional FDA

HSMN NewsFeed - 27 Sep 2010
Positive Reimbursement Coverage Issued for RedPath's PathFinderTG(R) Technology
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 2 Jul 2010
Lilly to Acquire Alnara Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Jul 2010
BioVex Appoints Steven Kelly as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2010
Celgene to Acquire Abraxis BioScience Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Jun 2010
Lantis Laser Signs Letter of Intent to Merge With Perio-Imaging Inc.
Devices Dental Mergers & Acquisitions

HSMN NewsFeed - 8 Jun 2010
New ABRAXANE(R) Data Demonstrates Potential in Patients with Advanced and Malignant Melanoma, Among the Toughest Cancers to Treat
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Jun 2010
Immunomedics Reports Updated Results of Targeted Therapy for Advanced Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 May 2010
Abbott Receives FDA Approval for CREON(R) to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectomy
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Apr 2010
OSI Pharmaceuticals Announces That Tarceva(R) Received Approval in the European Union for Maintenance Use in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 22 Mar 2010
Asuragen Appoints French Distributor Biomedical Diagnostics SA for Signature(R) Oncology Portfolio
Diagnostics Oncology Distribution

HSMN NewsFeed - 19 Mar 2010
OSI Pharmaceuticals Announces That Tarceva(R) Received a Positive Opinion from Health Authorities in the European Union for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 11 Feb 2010
NewLink Genetics Receives Special Protocol Assessment Approval from FDA for Pivotal Phase 3 Trial in Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 9 Feb 2010
BSD Medical Reports Initiation of a Phase III Study on Pancreatic Cancer Using the BSD-2000 Hyperthermia System in Combination with Chemotherapy
Devices Oncology

HSMN NewsFeed - 28 Jan 2010
Alnara Pharmaceuticals Secures $35 Million in Series B Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Jan 2010
Data Show Progression-Free Survival Advantage with Sutent(R) in Patients with Pancreatic Neuroendocrine Tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Jan 2010
FDA Extends Review Period for Tarceva Application for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Jan 2010
BioVex Appoints Tim Hanke as VP Commercial Operations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 14 Dec 2009
Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments
Devices Oncology

HSMN NewsFeed - 2 Dec 2009
ImmunoCellular Therapeutics Enters into Option Agreement with The University of Texas M. D. Anderson Cancer Center for a Novel Cancer Stem Cell Therapy
Regenerative Medicine Oncology

HSMN NewsFeed - 18 Nov 2009
Asuragen Signs Development and Worldwide Distribution Agreement with Life Technologies
Diagnostics Oncology Distribution

HSMN NewsFeed - 16 Nov 2009
OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Nov 2009
Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic Insufficiency
Biopharmaceuticals

HSMN NewsFeed - 10 Nov 2009
Scientific Presentations at 2009 ASTRO Meeting Highlight RapidArc(R) Radiotherapy Technology from Varian Medical Systems
Devices Oncology

HSMN NewsFeed - 5 Nov 2009
ABRAXANE(R) Receives Orphan Drug Status for the Treatment of Pancreatic Cancer and Stage IIB-IV Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 Nov 2009
Calypso Medical Studies Show Potential for Improving Radiotherapy Treatment Accuracy
Devices Oncology

HSMN NewsFeed - 29 Oct 2009
ASTRO Presentations Highlight Role of TomoTherapy(R) Technology in Combined Modality Approach to Treating Cancer
Devices Oncology

HSMN NewsFeed - 15 Oct 2009
Threshold Pharmaceuticals Licenses Glufosfamide to Eleison Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Oct 2009
Advanced U.S. Clinical Trial Confirms Single-Agent Efficacy of Rexin-G in Metastatic Pancreas Cancer: All Endpoints Achieved
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Aug 2009
Eurand Granted FDA Approval for ZENPEP(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Aug 2009
New Data from Phase III SATURN Study Showed Tarceva Extended Survival in Patients with Advanced Non-Small Cell Lung Cancer When Used Immediately after Initial Chemotherapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Jul 2009
New Data from Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Jul 2009
Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Jun 2009
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 Jun 2009
Epeius Biotechnologies' Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Jun 2009
ImmunoCellular Therapeutics Reports Additional Data from Promising Brain Cancer Clinical Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 May 2009
FDA Clears Boston Scientific's SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
Devices FDA

HSMN NewsFeed - 24 Apr 2009
Roche Announces Collaboration to Investigate New Treatment Strategy With Tarceva in Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Apr 2009
Immunomedics Reports Results That Could Expand Use of Milatuzumab in Cancer Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Mar 2009
OSI Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Tarceva as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 12 Mar 2009
Sutent Significantly Increases Progression Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors, Study Stopped Early
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Feb 2009
Novogen to Focus on Oncology Program
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Feb 2009
Immunomedics' hPAM4 Labeled With Yttrium-90 Receives Fast Track Designation From FDA for Therapy of Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 Feb 2009
pSivida Corp. Names Paul Ashton, Ph.D. President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 29 Jan 2009
GenVec Reduces Costs to Preserve Capital
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Jan 2009
Marshall Edwards, Inc. Granted IND for Triphendiol
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Nov 2008
Tarceva(R) (erlotinib) Endorsed by the U.K.'s National Institute for Health and Clinical Excellence for Use in Patients with Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Nov 2008
GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade in Locally Advanced Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Nov 2008
TNFerade(TM) Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 Oct 2008
CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008
Devices Oncology

HSMN NewsFeed - 22 Oct 2008
Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 16 Oct 2008
Boston Scientific Introduces the 'Platinum Standard'(1) in Biliary Metal Stenting with the International Launch of WallFlex(R) Biliary RX Stenting System
Devices Interventional

HSMN NewsFeed - 10 Sep 2008
AmpliMed Announces License Agreement with Handok Pharmaceuticals for Exclusive Rights to Cancer Therapeutic Amplimexon(R) in Korea
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Sep 2008
Philip Arlen, MD Joins Neogenix Oncology as President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Aug 2008
SciClone Pharmaceuticals Appoints Jeffery Lange as Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jul 2008
Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Jul 2008
Immunomedics Announces Worldwide License and Collaboration Agreement With Nycomed for Veltuzumab for Non-Cancer Indications
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 9 Jul 2008
FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 Jun 2008
MethylGene Reports Clinical Data for MGCD0103 at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Jun 2008
BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 May 2008
Patients With Pancreatic Cancer can Benefit From Avastin(R) Plus Tarceva(R)
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 May 2008
Phase III Clinical Study Using BSD Medical's Systems for Treating Pancreatic Cancer to Be Announced at ASCO
Devices Oncology

HSMN NewsFeed - 28 May 2008
Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 May 2008
Cyclacel's Sapacitabine Receives Orphan Designation for AML & MDS From EU Regulators
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 5 May 2008
Robotic Radiosurgery Course Yields Record Attendance
Devices Oncology

HSMN NewsFeed - 24 Apr 2008
Multiple Studies Demonstrate the Use of Hyperthermia Therapy in Treating Pancreatic Cancer
Devices Oncology

HSMN NewsFeed - 23 Apr 2008
Abraxis BioScience Reports Promising Clinical Data in Advanced Pancreatic Cancer Using a Combination of nab-Paclitaxel (ABRAXANE(R)) and Gemcitabine (Gemzar(R))
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Apr 2008
European Regulatory Agency Grants Orphan Status to Morphotek(R)'s Farletuzumab and MORAb-009
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 11 Apr 2008
ALIMTA(R) (pemetrexed for injection) Receives European Approval for Histologically-Based Use in First-Line Treatment of Most Common Lung Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 9 Apr 2008
Novacea Receives Notification From Schering-Plough of Termination of Collaboration Agreement
Biopharmaceuticals

HSMN NewsFeed - 8 Apr 2008
Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 20 Mar 2008
Immunomedics Develops New Immunoconjugates for Targeted Chemotherapy of Pancreatic and Other Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Mar 2008
EntreMed Announces 2008 Corporate and Clinical Program Priorities
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Mar 2008
The Mobetron Makes Groundbreaking Radiation Therapy Technique a Reality for Japanese Breast Cancer Patients
Devices Oncology

HSMN NewsFeed - 28 Feb 2008
Frederick J. Ruegsegger Elected to Novacea's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Feb 2008
MethylGene and Pharmion Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Feb 2008
Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Feb 2008
Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 11 Feb 2008
MethylGene and Pharmion Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 11 Feb 2008
Spectrum Pharmaceuticals Strengthens Management; Appoints Oncologist Richard A. Bender, MD as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Feb 2008
SciClone and Sigma-Tau Report Promising Interim Results From Phase 3 Hepatitis C Trial
Biopharmaceuticals

HSMN NewsFeed - 28 Jan 2008
Gloucester Pharmaceuticals Announces New Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Dec 2007
Judith A. Hemberger Elected to Novacea's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Dec 2007
OSI Pharmaceuticals Announces Launch Date of Tarceva(R) (erlotinib) in Japan
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 26 Nov 2007
NCCN Updates Pancreatic Adenocarcinoma Guidelines
Oncology

HSMN NewsFeed - 15 Nov 2007
BioVex Closes Second Round of Series E Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Oct 2007
Threshold Pharmaceuticals Announces Corporate Realignment
Biopharmaceuticals

HSMN NewsFeed - 25 Oct 2007
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2007
Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Oct 2007
Tarceva(R) (erlotinib) Earns Approval for Lung Cancer Patients in Japan
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 15 Oct 2007
OSI Pharmaceuticals Provides Additional Information about US Sales of Tarceva
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Oct 2007
China Medical Technologies Announces Receipt of Korean FDA Approval for its HIFU System
Devices Oncology Regulatory

HSMN NewsFeed - 20 Sep 2007
BioVex Appoints Dr. Leonard Post to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2007
OSI Pharmaceuticals Announces Patent Term Extension for Tarceva(R) (erlotinib)
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Sep 2007
OSI Pharmaceuticals Summarizes Data Presented on Tarceva(R) (erlotinib) at the 12th World Congress on Lung Cancer Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Sep 2007
Roche's Tarceva(R) Delivers Longer Life for Lung Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Aug 2007
YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 15 Aug 2007
BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Aug 2007
Oncoscience Ag, the European Partner of Ym Biosciences, Announces Completion of Patient Enrollment in Phase III Brain Cancer Trial of Nimotuzumab
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Aug 2007
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
Biopharmaceuticals

HSMN NewsFeed - 27 Jul 2007
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 18 Jul 2007
pSivida Strengthens its Position in Drug Delivery Sector
Biopharmaceuticals Drug Delivery Ophthalmology

HSMN NewsFeed - 12 Jul 2007
Point Therapeutics Update
Biopharmaceuticals

HSMN NewsFeed - 9 Jul 2007
BioVex Raises $22 Million in First Close of Series E Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Jul 2007
Reata Pharmaceuticals Closes $25 Million in Series E Funding
Biopharmaceuticals

HSMN NewsFeed - 28 Jun 2007
Bionovo Appoints Tom Chesterman as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jun 2007
Eurand's Zentase(TM) Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
Biopharmaceuticals

HSMN NewsFeed - 19 Jun 2007
OSI Pharmaceuticals Begins Clinical Development Program of OSI-906 in Patients with Advanced Solid Tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Jun 2007
OSI Pharmaceuticals Announces the Election of Kenneth B. Lee, Jr. to Its Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2007
Eurand Files NDA for Zentase(TM) for Exocrine Pancreatic Insufficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Jun 2007
Richard Juelis Joins Bionovo's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Jun 2007
OSI Pharmaceuticals Summarizes Data on Tarceva(R) (erlotinib) at the 2007 American Society of Clinical Oncology (ASCO) Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jun 2007
Pfizer to Advance Three Key Oncology Compounds into Phase 3 Trials in 2007, Company Tells Financial Analysts
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jun 2007
New Data Show Pfizer's Axitinib Prolonged Overall Survival in Advanced Pancreatic Cancer When Combined with Standard of Care Chemotherapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jun 2007
GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade(TM) at ASCO
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jun 2007
Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jun 2007
Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jun 2007
Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 May 2007
Point Therapeutics Reduces Costs by Cutting Work Force
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 May 2007
Rob Frankenberg, Ph.D. Joins Bionovo as Vice President of Drug Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2007
Talabostat Clinical Program Put on Clinical Hold by FDA
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 May 2007
Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 15 May 2007
Point Therapeutics Announces Interim Analysis to be Performed on Its Phase 3 Talabostat with Alimta Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 May 2007
pSivida Announces Board Change
Biopharmaceuticals Ophthalmology Drug Delivery Personnel

HSMN NewsFeed - 30 Apr 2007
Enzon Receives FDA Clearance of Its Recently Filed PEG-SN38 IND Application
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Apr 2007
SciClone Acquires Clinical-Stage Pancreatic Cancer Compound
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 26 Apr 2007
Avantogen Oncology, Inc. Completes Major Transaction With SciClone Pharmaceuticals, Inc.
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 25 Apr 2007
OSI Pharmaceuticals Announces Pivotal Phase III Tarceva(R) Study Published in the Journal of Clinical Oncology Showed Survival Improvement in Patients with Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Apr 2007
Thallion Presents Data at the 2007 Annual Meeting of the American Association of Cancer Research on its Oncology Drug Candidates ECO-4601 and CAP-232
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Apr 2007
AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and Drug-Resistant Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Apr 2007
Eisai Announces Completion of Acquisition of Morphotek
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Apr 2007
Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Apr 2007
Lilly Oncology Focused on Pharmacogenomics at AACR Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Apr 2007
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
Biopharmaceuticals Ophthalmology Drug Delivery Licensing

HSMN NewsFeed - 22 Mar 2007
Eisai To Acquire Morphotek
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Mar 2007
IntraOp Medical Delivers Third Mobetron, Advanced Intraoperative Electron Radiation Therapy System, to Japan
Devices Oncology

HSMN NewsFeed - 1 Mar 2007
Point Therapeutics Provides Clinical Update
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Feb 2007
Threshold Pharmaceuticals Announces That a Phase 3 Clinical Trial of Glufosfamide for Treatment of Pancreatic Cancer Did Not Meet Its Primary Endpoint
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Feb 2007
First patient enrolled in Stimuvax(R) Phase III clinical trial in patients with non-small cell lung cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Feb 2007
Gloucester Pharmaceuticals Appoints Pharmaceutical Veteran, Donald Hayden, as Vice-Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jan 2007
YM BioSciences announces termination of the tesmilifene Phase III pivotal trial in advanced breast cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Jan 2007
Gloucester Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase II Trial of Romidepsin in Patients with Peripheral T-Cell Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 29 Jan 2007
OSI Pharmaceuticals Announces European Regulatory Approval of Tarceva(R) for Treatment of Patients with Pancreatic Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 26 Jan 2007
GenVec Announces First Patient Treated with TNFerade(TM) for Head and Neck Cancer at University of Chicago
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Jan 2007
Point Therapeutics Announces Resignation of William Whelan from Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jan 2007
Cell Genesys Announces Encouraging Follow-Up Survival Data From Phase 2 Clinical Trial of GVAX(R) Immunotherapy for Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Jan 2007
Point Therapeutics Provides Preliminary Results from Phase 2 Metastatic Pancreatic Cancer Study
Biopharmaceuticals

HSMN NewsFeed - 11 Jan 2007
GenVec Receives Clearance From FDA for EUS Administration of TNFerade(TM)
Biopharmaceuticals Oncology FDA Drug Delivery

HSMN NewsFeed - 5 Jan 2007
OSI Pharmaceuticals Licenses Its Glucokinase Activator Program for the Treatment of Type 2 Diabetes to Eli Lilly and Company
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 2 Jan 2007
Phase II clinical trial of Biomira's PX-12 in patients with advanced pancreatic cancer now open for patient enrollment
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Dec 2006
The Multiple Myeloma Research Consortium (MMRC) and Keryx Biopharmaceuticals Commence Multi-Center Combination Study for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Dec 2006
Tapestry Pharmaceuticals Appoints Donald H. Picker, Ph.D. As President
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Dec 2006
pSivida Enters Licensing Negotiations with Major Global Pharma for Drug Delivery Technologies
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 19 Dec 2006
European Medical Studies: Shorter Treatment Cycles, Improved Tumor Control and Longer Life Expectancy for Cancer Patients Treated with IOERT
Devices Oncology

HSMN NewsFeed - 19 Dec 2006
GenVec Announces Efficacy Update in Phase II/III Clinical Trial of TNFerade(TM) in Locally Advanced Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Dec 2006
OSI Pharmaceuticals Announces Appointment of Pablo J. Cagnoni, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Dec 2006
OSI Pharmaceuticals Announces That Tarceva(R) Received Positive Opinion from Health Authorities in European Union for the Treatment of Patients with Pancreatic Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 14 Dec 2006
GenVec Announces Completion of Interim Safety Data Analysis for Phase II/III Trial with TNFerade(TM) in Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Dec 2006
OSI Pharmaceuticals Grants License to Bristol-Myers Squibb under Dipeptidyl Peptidase IV (DPIV) Patent Portfolio for the Treatment of Type 2 Diabetes
Biopharmaceuticals Licensing

HSMN NewsFeed - 11 Dec 2006
Actelion-1 -- First Tissue-Targeting Endothelin Receptor Antagonist -- in Phase III for Pulmonary Hypertension
Biopharmaceuticals

HSMN NewsFeed - 29 Nov 2006
Threshold Pharmaceuticals Announces Change in Guidance for Release of Phase 3 Trial Results in Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Nov 2006
Monoclonal Antibody, MORAb-009, Receives FDA Orphan Drug Designation for the Indication of Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 1 Nov 2006
Cell Genesys Announces Management Change
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 31 Oct 2006
Biomira Announces Acquisition of ProlX Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Oct 2006
Avantogen Oncology Inc. Announces FDA Acceptance Of Its IND For The Novel Cancer Drug Candidate, RP101
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 Oct 2006
IntraOp Delivers Mobetron to Nagoya University Hospital
Devices Oncology

HSMN NewsFeed - 24 Oct 2006
Myriad Genetics Sponsors Clinical Trial in Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Oct 2006
Threshold Pharmaceuticals Announces Management Update
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Oct 2006
First Patient Implanted in pSivida European Pancreatic Cancer Study
Devices Oncology

HSMN NewsFeed - 5 Oct 2006
Curis, Inc. Announces Genentech Filing of Investigational New Drug Application for Systemic Administration of a Hedgehog Antagonist
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2006
Avantogen Oncology Inc. Files IND Application for RP101
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 Oct 2006
Patients With HER2-Positive Breast Cancer Significantly Benefit From Addition of Xeloda to Herceptin and Taxotere Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Sep 2006
OSI Pharmaceuticals Launches Study of Tarceva(R) as Adjuvant Treatment for Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Sep 2006
Threshold Pharmaceuticals Announces Management Update
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 20 Jul 2006
YM BioSciences reports anti-EGFr drug nimotuzumab approved in India for treatment of head and neck cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 19 Jul 2006
BSD Medical's BSD-2000 May Provide Hope for Pancreatic Cancer Patients
Devices Oncology

HSMN NewsFeed - 12 Jul 2006
IOERT Shown to be Effective in Treating Pancreatic Cancer
Devices Oncology

HSMN NewsFeed - 28 Jun 2006
Therion Reports Results of Phase 3 PANVAC-VF Trial and Announces Plans for Company Sale
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Jun 2006
Chemokine Therapeutics names Guy Ely, MD as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2006
Phase III Study of Avastin(R) in Advanced Pancreatic Cancer Does Not Meet Primary Endpoint
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Jun 2006
OSI Pharmaceuticals and Pfizer Announce Phase IV Macugen(R)(pegaptanib sodium injection) Maintenance Trial in Neovascular Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 2 Jun 2006
SuperGen Receives U.S. Patent For Nipent(R)(Pentostatin For Injection)
Biopharmaceuticals

HSMN NewsFeed - 1 Jun 2006
Threshold Announces Data Safety Monitoring Board Recommends Glufosfamide Phase 3 Clinical Trial Continue to Completion
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Jun 2006
Preliminary Topline Efficacy Results from Phase II Data Show Macugen(R) (pegaptanib sodium injection) Maintained or Improved Vision in over 90 Percent of Patients with Macular Edema Associated with Central Retinal Vein Occlusion (CRVO)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 1 Jun 2006
Point Therapeutics Receives Fast Track Designation for Talabostat
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 31 May 2006
Intraop Receives Two Mobetron Orders from Japan
Devices Oncology Surgery

HSMN NewsFeed - 25 May 2006
pSivida Provides Update on BrachySil(TM) Liver Program: Expansion of Multicenter Clinical Trial
Biopharmacetuicals Oncology Drug Delivery

HSMN NewsFeed - 23 May 2006
Long-Term Results from TNFerade(TM) Pancreatic Cancer Study and Updated Survival Results from TNFerade(TM) Esophageal Cancer Study Both Reported at Digestive Disease Week
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 May 2006
OSI Pharmaceuticals Summarizes Macugen(R) (pegaptanib sodium injection) Data Presented at Association for Research in Vision and Ophthalmology (ARVO) Meeting
Biopharmaceuticals Ophthalmology

Return to NewsFeed

Additional items found! 313

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 313 additional stories matching:
Pancreatic Cancer
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.